These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29702481)

  • 41. Metformin can block precancerous progression to invasive tumors of bladder through inhibiting STAT3-mediated signaling pathways.
    Pan Q; Yang GL; Yang JH; Lin SL; Liu N; Liu SS; Liu MY; Zhang LH; Huang YR; Shen RL; Liu Q; Gao JX; Bo JJ
    J Exp Clin Cancer Res; 2015 Aug; 34(1):77. PubMed ID: 26245871
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cryptotanshinone suppresses the proliferation and induces the apoptosis of pancreatic cancer cells via the STAT3 signaling pathway.
    Ge Y; Yang B; Chen Z; Cheng R
    Mol Med Rep; 2015 Nov; 12(5):7782-8. PubMed ID: 26459366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sugiol inhibits STAT3 activity via regulation of transketolase and ROS-mediated ERK activation in DU145 prostate carcinoma cells.
    Jung SN; Shin DS; Kim HN; Jeon YJ; Yun J; Lee YJ; Kang JS; Han DC; Kwon BM
    Biochem Pharmacol; 2015 Sep; 97(1):38-50. PubMed ID: 26212545
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Paeoniflorin Sensitizes Breast Cancer Cells to Tamoxifen by Downregulating microRNA-15b via the FOXO1/CCND1/β-Catenin Axis.
    Wang Y; Wang Q; Li X; Luo G; Shen M; Shi J; Wang X; Tang L
    Drug Des Devel Ther; 2021; 15():245-257. PubMed ID: 33519190
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
    Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
    Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of combination therapy with a novel bisphosphonate, minodronate (YM529), and docetaxel on a model of bone metastasis by human transitional cell carcinoma.
    Inoue K; Karashima T; Fukata S; Nomura A; Kawada C; Kurabayashi A; Furihata M; Ohtsuki Y; Shuin T
    Clin Cancer Res; 2005 Sep; 11(18):6669-77. PubMed ID: 16166446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
    Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Jolkinolide B targets thioredoxin and glutathione systems to induce ROS-mediated paraptosis and apoptosis in bladder cancer cells.
    Sang J; Li W; Diao HJ; Fan RZ; Huang JL; Gan L; Zou MF; Tang GH; Yin S
    Cancer Lett; 2021 Jul; 509():13-25. PubMed ID: 33836250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lycorine inhibits the growth and metastasis of breast cancer through the blockage of STAT3 signaling pathway.
    Wang J; Xu J; Xing G
    Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):771-779. PubMed ID: 28910973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo.
    Shen L; Zhang G; Lou Z; Xu G; Zhang G
    BMC Complement Altern Med; 2017 Feb; 17(1):106. PubMed ID: 28187727
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer.
    Huang S; Wang D; Zhang S; Huang X; Wang D; Ijaz M; Shi Y
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):685-696. PubMed ID: 28779263
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ellagic Acid Inhibits Bladder Cancer Invasiveness and In Vivo Tumor Growth.
    Ceci C; Tentori L; Atzori MG; Lacal PM; Bonanno E; Scimeca M; Cicconi R; Mattei M; de Martino MG; Vespasiani G; Miano R; Graziani G
    Nutrients; 2016 Nov; 8(11):. PubMed ID: 27879653
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A pumpkin polysaccharide induces apoptosis by inhibiting the JAK2/STAT3 pathway in human hepatoma HepG2 cells.
    Shen W; Chen C; Guan Y; Song X; Jin Y; Wang J; Hu Y; Xin T; Jiang Q; Zhong L
    Int J Biol Macromol; 2017 Nov; 104(Pt A):681-686. PubMed ID: 28634059
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer.
    Zhu K; Fang W; Chen Y; Lin S; Chen X
    Oncol Rep; 2014 Sep; 32(3):1234-42. PubMed ID: 25017445
    [TBL] [Abstract][Full Text] [Related]  

  • 55. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
    Fang L; Wang H; Zhou L; Yu D
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744
    [TBL] [Abstract][Full Text] [Related]  

  • 56. GYY4137, a hydrogen sulfide (H₂S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway.
    Lu S; Gao Y; Huang X; Wang X
    Int J Oncol; 2014 Apr; 44(4):1259-67. PubMed ID: 24535538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Paeoniflorin inhibits function of synoviocytes pretreated by rIL-1α and regulates EP4 receptor expression.
    Chang Y; Zhang L; Wang C; Jia XY; Wei W
    J Ethnopharmacol; 2011 Oct; 137(3):1275-82. PubMed ID: 21840386
    [TBL] [Abstract][Full Text] [Related]  

  • 58. STAT3 inhibition by WP1066 suppresses the growth and invasiveness of bladder cancer cells.
    Tsujita Y; Horiguchi A; Tasaki S; Isono M; Asano T; Ito K; Asano T; Mayumi Y; Kushibiki T
    Oncol Rep; 2017 Oct; 38(4):2197-2204. PubMed ID: 28849140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.
    Liu CY; Su JC; Ni MH; Tseng LM; Chu PY; Wang DS; Tai WT; Kao YP; Hung MH; Shiau CW; Chen KF
    Breast Cancer Res Treat; 2014 Jul; 146(1):71-84. PubMed ID: 24903225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FXR agonists enhance the sensitivity of biliary tract cancer cells to cisplatin via SHP dependent inhibition of Bcl-xL expression.
    Wang W; Zhan M; Li Q; Chen W; Chu H; Huang Q; Hou Z; Man M; Wang J
    Oncotarget; 2016 Jun; 7(23):34617-29. PubMed ID: 27127878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.